20-32019105-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001365692.1(CCM2L):c.629G>A(p.Gly210Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000255 in 1,176,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001365692.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCM2L | NM_001365692.1 | c.629G>A | p.Gly210Asp | missense_variant | 5/10 | ENST00000452892.3 | NP_001352621.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCM2L | ENST00000452892.3 | c.629G>A | p.Gly210Asp | missense_variant | 5/10 | 2 | NM_001365692.1 | ENSP00000392448.2 | ||
CCM2L | ENST00000262659.12 | c.629G>A | p.Gly210Asp | missense_variant | 5/9 | 1 | ENSP00000262659.8 | |||
ENSG00000226239 | ENST00000653258.1 | n.704+9823C>T | intron_variant | |||||||
ENSG00000226239 | ENST00000662576.1 | n.815+9823C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00000667 AC: 1AN: 149882Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000195 AC: 2AN: 1027092Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 484386
GnomAD4 genome AF: 0.00000667 AC: 1AN: 149882Hom.: 0 Cov.: 33 AF XY: 0.0000137 AC XY: 1AN XY: 73088
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.629G>A (p.G210D) alteration is located in exon 5 (coding exon 5) of the CCM2L gene. This alteration results from a G to A substitution at nucleotide position 629, causing the glycine (G) at amino acid position 210 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at